The first Veracyte trade was made in Q4 2020.
Since then Paul Tudor Jones II bought shares seven more times and sold shares on eight occasions. The investor completely sold their stake between Q4 2024 and Q1 2025.
Avg closing price
Price range
Sold -20.3 Thousand shares
Q1 2025
Avg closing price
$38.29
Price range
$29.65
-
$46.14
Sold 50.2% shares (-20.5 Thousand shares)
Q4 2024
Avg closing price
$38.06
Price range
$31.92
-
$44.40
Increased shares by 5.1% (+1.99 Thousand shares)
Q3 2024
Avg closing price
$28.08
Price range
$21.00
-
$35.25
New holding (+38.9 Thousand shares)
Q2 2024
Avg closing price
$21.03
Price range
$18.86
-
$23.55
Sold -34 Thousand shares
Q3 2023
Avg closing price
$25.72
Price range
$22.33
-
$29.92
Sold 5.1% shares (-1.83 Thousand shares)
Q2 2023
Avg closing price
$24.24
Price range
$20.96
-
$26.99
New holding (+35.8 Thousand shares)
Q1 2023
Avg closing price
$24.17
Price range
$20.58
-
$27.89
Sold -31 Thousand shares
Q4 2022
Avg closing price
$23.24
Price range
$15.31
-
$29.94
New holding (+31 Thousand shares)
Q3 2022
Avg closing price
$22.50
Price range
$16.58
-
$27.90
Sold -24.1 Thousand shares
Q2 2022
Avg closing price
$20.20
Price range
$15.45
-
$29.52
Increased shares by 22.6% (+4.45 Thousand shares)
Q1 2022
Avg closing price
$28.60
Price range
$21.94
-
$42.51
New holding (+19.6 Thousand shares)
Q4 2021
Avg closing price
$44.18
Price range
$36.09
-
$53.79
Sold -19.2 Thousand shares
Q3 2021
Avg closing price
$43.64
Price range
$35.62
-
$52.97
Increased shares by 292.0% (+14.3 Thousand shares)
Q2 2021